- Home
- AUPH vs NFJ Comparison
AUPH vs NFJ Comparison
Compare AUPH & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- NFJ
- Stock Information
- Founded
- AUPH 1993
- NFJ 2005
- Country
- AUPH Canada
- NFJ United States
- Employees
- AUPH N/A
- NFJ N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- NFJ Finance: Consumer Services
- Sector
- AUPH Health Care
- NFJ Finance
- Exchange
- AUPH Nasdaq
- NFJ Nasdaq
- Market Cap
- AUPH 1.1B
- NFJ 1.2B
- IPO Year
- AUPH 1999
- NFJ N/A
- Fundamental
- Price
- AUPH $7.93
- NFJ $12.76
- Analyst Decision
- AUPH Strong Buy
- NFJ
- Analyst Count
- AUPH 3
- NFJ 0
- Target Price
- AUPH $10.33
- NFJ N/A
- AVG Volume (30 Days)
- AUPH 1.0M
- NFJ 223.5K
- Earning Date
- AUPH 02-27-2025
- NFJ 01-01-0001
- Dividend Yield
- AUPH N/A
- NFJ 9.01%
- EPS Growth
- AUPH N/A
- NFJ N/A
- EPS
- AUPH N/A
- NFJ N/A
- Revenue
- AUPH $220,361,000.00
- NFJ N/A
- Revenue This Year
- AUPH $36.97
- NFJ N/A
- Revenue Next Year
- AUPH $16.43
- NFJ N/A
- P/E Ratio
- AUPH N/A
- NFJ N/A
- Revenue Growth
- AUPH 38.72
- NFJ N/A
- 52 Week Low
- AUPH $4.71
- NFJ $10.45
- 52 Week High
- AUPH $10.67
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- AUPH 47.47
- NFJ 42.56
- Support Level
- AUPH $7.50
- NFJ $12.77
- Resistance Level
- AUPH $8.12
- NFJ $13.01
- Average True Range (ATR)
- AUPH 0.27
- NFJ 0.12
- MACD
- AUPH 0.02
- NFJ -0.02
- Stochastic Oscillator
- AUPH 53.49
- NFJ 5.56
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. Its primary investment objective is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.